Interleukin-8-Induced Invasion Assay in Triple-Negative Breast Cancer Cells
The pro-inflammatory and pro-angiogenic chemokine interleukin-8 (IL-8, CXCL8) induces proliferation and invasion of solid tumor cells. In many types of solid cancer, including triple-negative breast cancer (TNBC), the IL-8 expression is induced by proteasome inhibition. In this chapter, we describe a protocol for the analysis of TNBC cell invasion induced by IL-8 in response to proteasome inhibition by bortezomib (BZ). Using this approach, we show that BZ increases the invasion ability of TNBC cells, and that the BZ-increased TNBC cell invasion is suppressed by IκB kinase (IKK) inhibition, which also decreases the IL-8 expression. The experimental protocol includes the cell invasion assay, microscopic evaluation of the invading cells, and quantitative analysis of the obtained images. This protocol should be applicable also for measurement of chemokine-induced tumor cell invasion in other types of cancer cells.
Key wordsBortezomib Cancer cell invasion Chemokines Interleukin-8 IκB kinase Proteasome inhibition Triple-negative breast cancer
This work was supported by NIH grant CA202775 to I. Vancurova.
- 17.Singha B, Gatla HR, Manna S, Chang TP, Sanacora S, Poltoratsky V et al (2014) Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to IL-8 promoter, resulting in increased IL-8 production in ovarian cancer cells. J Biol Chem 289:2687–2700CrossRefGoogle Scholar
- 18.Uddin MM, Zou Y, Sharma T, Gatla HR, Vancurova I (2018) Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: opportunity for combination therapy. PLoS One 13(8):e0201858. https://doi.org/10.1371/journal.pone.0201858CrossRefPubMedPubMedCentralGoogle Scholar